{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:38:25Z","timestamp":1792802305840,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00fq5cm18","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.sleep.2026.109264","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:34:56Z","timestamp":1789540496000},"page":"109264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Perceived effectiveness, tolerability, and discontinuation of lemborexant in real-world use: Evidence from online patient reports"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-8297","authenticated-orcid":false,"given":"Abanoub J.","family":"Armanious","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra R.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-458X","authenticated-orcid":false,"given":"Caitlin E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-8607","authenticated-orcid":false,"given":"Morgan H.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib1","first-page":"45","article-title":"The night and day challenge of sleep disorders and insomnia: a narrative review","volume":"52","author":"San","year":"2024","journal-title":"Actas Esp Psiquiatr"},{"issue":"5 Suppl","key":"10.1016\/j.sleep.2026.109264_bib2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5664\/jcsm.26929","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2026.109264_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5664\/jcsm.8986","article-title":"Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline","volume":"17","author":"Edinger","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2026.109264_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical Practice Guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice Guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2026.109264_bib5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"issue":"2","key":"10.1016\/j.sleep.2026.109264_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13181-013-0294-y","article-title":"In the Zzz zone: the effects of Z-drugs on human performance and driving","volume":"9","author":"Gunja","year":"2013","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.sleep.2026.109264_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/NDT.S4234","article-title":"New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists","volume":"5","author":"Hardeland","year":"2009","journal-title":"Neuropsychiatric Dis Treat"},{"issue":"4","key":"10.1016\/j.sleep.2026.109264_bib8","first-page":"169","article-title":"Cardiovascular considerations in antidepressant therapy: an evidence-based review","volume":"8","author":"Yekehtaz","year":"2013","journal-title":"J Tehran Heart Cent"},{"issue":"3","key":"10.1016\/j.sleep.2026.109264_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/wps.20674","article-title":"The assessment and management of insomnia: an update","volume":"18","author":"AD","year":"2019","journal-title":"World Psychiatry"},{"issue":"7","key":"10.1016\/j.sleep.2026.109264_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039131","article-title":"Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone","volume":"7","author":"Morairty","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.sleep.2026.109264_bib10","first-page":"264","article-title":"Suvorexant, a dual orexin receptor antagonist for the management of insomnia","volume":"39","author":"Bennett","year":"2014","journal-title":"P t"},{"key":"10.1016\/j.sleep.2026.109264_bib11","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.2147\/DDDT.S73224","article-title":"Profile of suvorexant in the management of insomnia","volume":"9","author":"Sutton","year":"2015","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41398-025-03439-8","article-title":"Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis","volume":"15","author":"Kishi","year":"2025","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-026-03974-y","article-title":"Optimal use of dual orexin receptor antagonists for insomnia: a network meta-analysis perspective","volume":"16","author":"Kishi","year":"2026","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.sleep.2026.109264_bib14","series-title":"StatPearls. StatPearls Publishing Copyright \u00a9 2024","article-title":"Lemborexant","author":"Ardeljan","year":"2024"},{"issue":"9","key":"10.1016\/j.sleep.2026.109264_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa123","article-title":"Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2","volume":"43","author":"K\u00e4rpp\u00e4","year":"2020","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib17","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.2196\/jmir.1157","article-title":"Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the internet","volume":"11","author":"Eysenbach","year":"2009","journal-title":"J Med Internet Res"},{"issue":"11","key":"10.1016\/j.sleep.2026.109264_bib16","doi-asserted-by":"crossref","DOI":"10.2196\/13371","article-title":"Adverse events due to insomnia drugs reported in a regulatory database and online patient reviews: comparative study","volume":"21","author":"Borchert","year":"2019","journal-title":"J Med Internet Res"},{"issue":"4","key":"10.1016\/j.sleep.2026.109264_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.psycom.2024.100195","article-title":"Patient perceptions of lisdexamfetamine as a treatment for binge eating disorder: an exploratory qualitative and quantitative analysis","volume":"4","author":"Armanious","year":"2024","journal-title":"Psychiatr Res Commun"},{"key":"10.1016\/j.sleep.2026.109264_bib19","doi-asserted-by":"crossref","DOI":"10.2196\/78391","article-title":"Patient perceptions of ozempic (Semaglutide) for weight loss: mixed methods analysis of online medication reviews","volume":"28","author":"Armanious","year":"2026","journal-title":"J Med Internet Res"},{"issue":"2","key":"10.1016\/j.sleep.2026.109264_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.sleep.2026.109264_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1436405","article-title":"Data mining and safety analysis of dual orexin receptor antagonists (DORAs): a real-world pharmacovigilance study based on the FAERS database","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.sleep.2026.109264_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40268-024-00462-w","article-title":"Safety and efficacy of lemborexant in insomnia patients: results of a postmarketing observational study of dayvigo(\u00ae) tablets","volume":"24","author":"Mishima","year":"2024","journal-title":"Drugs R&D"},{"issue":"11","key":"10.1016\/j.sleep.2026.109264_bib23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.5664\/jcsm.6800","article-title":"Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the treatment of insomnia disorder: results from a bayesian, adaptive, randomized, Double-Blind, placebo-controlled study","volume":"13","author":"Murphy","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"10.1016\/j.sleep.2026.109264_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and Zolpidem Tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sleep.2026.109264_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.sleep.2021.01.048","article-title":"Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial","volume":"80","author":"Yardley","year":"2021","journal-title":"Sleep Med"},{"issue":"10347","key":"10.1016\/j.sleep.2026.109264_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2026.109264_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2025.106823","article-title":"Efficacy and safety of lemborexant in patients with insomnia: a systematic review and meta-analysis","volume":"136","author":"Khan","year":"2025","journal-title":"Sleep Med"},{"issue":"9","key":"10.1016\/j.sleep.2026.109264_bib28","first-page":"1296","article-title":"Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis","volume":"27","author":"McElroy","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.sleep.2026.109264_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1495965","article-title":"Efficacy and safety of Lemborexant in treating adult patients with insomnia in China: a single-center, retrospective observational study","volume":"16","author":"Jian","year":"2025","journal-title":"Front Neurol"},{"key":"10.1016\/j.sleep.2026.109264_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/NSS.S448871","article-title":"Assessing the real-world, long-term impact of lemborexant on sleep quality in a home-based clinical study","volume":"16","author":"Miyata","year":"2024","journal-title":"Nat Sci Sleep"},{"issue":"Suppl 1","key":"10.1016\/j.sleep.2026.109264_bib31","doi-asserted-by":"crossref","first-page":"A52","DOI":"10.1093\/sleepadvances\/zpab014.141","article-title":"P097 incidence of abnormal dreams and nightmares with lemborexant in adults with insomnia: results from two phase 3 studies","volume":"2","author":"Roth","year":"2021","journal-title":"Sleep Adv"},{"key":"10.1016\/j.sleep.2026.109264_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1145\/1562764.1562800","article-title":"Overcoming the J-shaped distribution of product reviews","volume":"52","author":"Hu","year":"2009","journal-title":"Commun ACM"},{"key":"10.1016\/j.sleep.2026.109264_bib33","first-page":"1","article-title":"Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study","author":"Sun","year":"2025","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib34","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1002\/pcn5.85","article-title":"Comparative efficacy and safety of suvorexant and lemborexant for insomnia treatment","volume":"2","author":"Hayashi","year":"2023","journal-title":"PCN Rep"},{"issue":"5","key":"10.1016\/j.sleep.2026.109264_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/joim.13406","article-title":"Hypocretins (orexins): the ultimate translational neuropeptides","volume":"291","author":"Jacobson","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.sleep.2026.109264_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fendo.2013.00018","article-title":"The physiological role of orexin\/hypocretin neurons in the regulation of sleep\/wakefulness and neuroendocrine functions","volume":"4","author":"Inutsuka","year":"2013","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.sleep.2026.109264_bib51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/pcn.70036","article-title":"Comparative effects of hypnotic agents on sleep architecture and respiratory outcomes in obstructive sleep apnea: a systematic review and network meta-analysis","volume":"80","author":"Kishi","year":"2026","journal-title":"Psychiatr Clin Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41398-024-03087-4","article-title":"Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review","volume":"14","author":"Kishi","year":"2024","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00325481.2020.1823724","article-title":"Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials","volume":"133","author":"Moline","year":"2021","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.sleep.2026.109264_bib54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5664\/jcsm.8294","article-title":"Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening","volume":"16","author":"Murphy","year":"2020","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"13","key":"10.1016\/j.sleep.2026.109264_bib39","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1017\/S0033291722000356","article-title":"Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents","volume":"52","author":"Ikeda","year":"2022","journal-title":"Psychol Med"},{"issue":"6","key":"10.1016\/j.sleep.2026.109264_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11606-008-0568-2","article-title":"Medicare beneficiaries and free prescription drug samples: a national survey","volume":"23","author":"Tjia","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sleep.2026.109264_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105053","article-title":"Nonclinical evaluation of abuse liability of the dual orexin receptor antagonist lemborexant","volume":"127","author":"Asakura","year":"2021","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"10.1016\/j.sleep.2026.109264_bib42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00213-023-06320-y","article-title":"The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the controlled substances act","volume":"240","author":"Moline","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.sleep.2026.109264_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000514965","article-title":"The insomnia-addiction positive feedback loop: role of the orexin system","volume":"45","author":"Fragale","year":"2021","journal-title":"Front Neurol Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41386-022-01404-3","article-title":"Sleep disturbance in substance use disorders: the orexin (hypocretin) system as an emerging pharmacological target","volume":"48","author":"Gyawali","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.sleep.2026.109264_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-020-0619-x","article-title":"Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?","author":"James","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.sleep.2026.109264_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2021.09.002","article-title":"Orexin (hypocretin) and addiction","author":"Mehr","year":"2021","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.sleep.2026.109264_bib47","article-title":"Emerging medications and pharmacological treatment approaches for substance use disorders","author":"Raymond","year":"2024","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"10.1016\/j.sleep.2026.109264_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304461","article-title":"Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder","volume":"19","author":"White","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.sleep.2026.109264_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40337-022-00704-9","article-title":"Sleep disruption as a potential contributor to the worsening of eating disorder pathology during the COVID-19-pandemic","volume":"10","author":"Mehr","year":"2022","journal-title":"J Eat Disord"},{"key":"10.1016\/j.sleep.2026.109264_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-021-01052-z","article-title":"Sleep dysregulation in binge eating disorder and \u201cfood addiction\u201d: the orexin (hypocretin) system as a potential neurobiological link","author":"Mehr","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.sleep.2026.109264_bib50","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1207\/S15327957PSPR0504_2","article-title":"Negativity bias, negativity dominance, and contagion","volume":"5","author":"Rozin","year":"2001","journal-title":"Pers Soc Psychol Rev"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945726005034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945726005034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:07:33Z","timestamp":1792800453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945726005034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":54,"alternative-id":["S1389945726005034"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2026.109264","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perceived effectiveness, tolerability, and discontinuation of lemborexant in real-world use: Evidence from online patient reports","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2026.109264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109264"}}